C=C1C2[C@H](OC(C)=O)[C@@H]3CC(=O)[C@@]4(C)OC[C@@]3(C)[C@]4(O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@]2(COC(=O)c2ccccc2)[C@@H](OC(C)=O)C[C@@H]1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?